| 000 | 01839 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250511210016.0 | ||
| 264 | 0 | _c19920424 | |
| 008 | 199204s 0 0 eng d | ||
| 022 | _a0013-7219 | ||
| 024 | 7 |
_a10.1507/endocrj1954.38.369 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTanaka, T | |
| 245 | 0 | 0 |
_aA dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprolide acetate depot, TAP-144-SR) in the treatment of central precocious puberty. The TAP-144-SR CPP Study Group. _h[electronic resource] |
| 260 |
_bEndocrinologia japonica _cAug 1991 |
||
| 300 |
_a369-76 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_a17-Hydroxycorticosteroids _xurine |
| 650 | 0 | 4 |
_a17-Ketosteroids _xurine |
| 650 | 0 | 4 |
_aAdrenal Glands _xdrug effects |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDehydroepiandrosterone _xblood |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEstradiol _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFollicle Stimulating Hormone _xurine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoradiometric Assay |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
| 650 | 0 | 4 |
_aLeuprolide _xpharmacology |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xurine |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPuberty, Precocious _xdrug therapy |
| 650 | 0 | 4 |
_aTestosterone _xblood |
| 700 | 1 | _aHibi, I | |
| 700 | 1 | _aKato, K | |
| 700 | 1 | _aSaito, S | |
| 700 | 1 | _aShimizu, N | |
| 700 | 1 | _aSuwa, S | |
| 700 | 1 | _aNakajima, H | |
| 773 | 0 |
_tEndocrinologia japonica _gvol. 38 _gno. 4 _gp. 369-76 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1507/endocrj1954.38.369 _zAvailable from publisher's website |
| 999 |
_c1845586 _d1845586 |
||